Prospecting gene therapy of implant infections

International Journal of Artificial Organs

Volumn 32, Issue 9, 2009, Pages 689-695

  Costerton, William J ^a   Montanaro, Lucio ^b,c   Balaban, Naomi ^d   Arciola, Carla Renata ^b,c  

^a ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Agr; Antibiotic resistance; Biofilm; Enterococcus faecalis; Gene therapy; Horizontal gene transfer; Implant infection; Peptide nucleic acid (PNA); Pseudomonas aeruginosa; Quorum sensing; RNAIII activating protein (RAP); RNAIII inhibiting peptide (RIP); Staphylococcus aureus

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BIOFILMS; GENE THERAPY; GENE TRANSFER; NUCLEIC ACIDS; PEPTIDES;

AGR; ANTIBIOTICS RESISTANCE; ENTEROCOCCUS FAECALIS; HORIZONTAL GENE TRANSFER; IMPLANT INFECTIONS; PEPTIDE NUCLEIC ACID; PSEUDOMONAS AERUGINOSA; QUORUM-SENSING; RNAIII-ACTIVATING PROTEIN; RNAIII-INHIBITING PEPTIDE;

BACTERIA;

ADHESIN; ANTIBIOTIC AGENT; ENTEROTOXIN; EXFOLIATIN; PEPTIDE NUCLEIC ACID; RIBONUCLEASE H;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTISENSE THERAPY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BIOFILM; DNA REPLICATION; ENTEROCOCCUS FAECALIS; GENE SILENCING; GENE THERAPY; HORIZONTAL GENE TRANSFER; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PROSTHESIS INFECTION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 70549089786     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880903200919     Document Type: Review

References (59)

1. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006; 27: 2331-9.
2. Arciola CR, An YH, Campoccia D, Donati ME, Montanaro L. Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif Organs 2005; 28: 1091-100.
3. Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med 1996; 335: 1445-53.
4. Witte W. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999; 44 (Suppl A): S1-9.
5. Struelens M, Denis O. Methicillin resistant Staphylococcus aureus: toward a coordinated response to a continuing challenge. Euro Surveill 2000; 5: 25-26.
6. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-9. (Comment in: Trends Microbiol 2001; 9: 204.)
7. Campoccia D, Baldassarri L, Pirini V, Ravaioli S, Montanaro L, Arciola CR. Molecular epidemiology of Staphylococcus aureus from implant orthopaedic infections: ribotypes, agr polymorphism, leukocidal toxins and antibiotic resistance. Biomaterials 2008; 29: 4108-16.
8. Campoccia D, Montanaro L, von Eiff C, Pirini V, Ravaioli S, Becker K, Arciola CR. Cluster analysis of ribotyping profiles of Staphylococcus epidermidis isolates recovered from foreign body-associated orthopedic infections. J Biomed Mater Res A 2009; 88: 664-72.
9. Campoccia D, Montanaro L, Pirini V, Ravaioli S, Arciola CR. Prevalence of genes for aminoglycoside-modifying enzymes in Staphylococcus epidermidis isolates from orthopedic postsurgical and implant-related infections. J Biomed Mater Res A 2009; 88: 654-63.
10. Arciola CR, Baldassarri L, Campoccia D, Creti R, Pirini V, Huebner J, Montanaro L. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials 2008; 29: 580-6.
11. Montanaro L, Campoccia D, Pirini V, Ravaioli S, Otto M, Arciola CR. Antibiotic multiresistance strictly associated with IS256 and ica genes in Staphylococcus epidermidis strains from implant orthopedic infections. J Biomed Mater Res A 2007; 83: 813-8.
12. Arciola CR, Campoccia D, An YH, et al. Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int J Artif Organs 2006; 29: 395-401.
13. Barlow M. What antimicrobial resistance has taught us about horizontal gene transfer. Methods Mol Biol 2009; 532: 397-411.
14. Boerlin P, Reid-Smith RJ. Antimicrobial resistance: its emergence and transmission. Anim Health Res Rev 2008; 9: 115-26.
15. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005; 28: 1062-8.
16. Ray A, Nordén B. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J 2000; 14: 1041-60.
17. Lundin KE, Good L, Strömberg R, Gräslund A, Smith CI. Biological activity and biotechnological aspects of peptide nucleic acid. Adv Genet 2006; 56: 1-51.
18. Egholm M, Buchardt O, Christensen L, et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 1993; 365: 566-8. (Comment in: Nature 1993; 365: 490-2.)
19. Knudsen H, Nielsen PE. Antisense properties of duplex-and triplex-forming PNAs. Nucleic Acids Res 1996; 24: 494-500.
20. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 1997; 15: 212-5.
21. Diviacco S, Rapozzi V, Xodo L, Helene C, Quadrifoglio F, Giovannangeli C. Site-directed inhibition of DNA replication by triple helix formation. FASEB J 2001; 15: 2660-8.
22. Hancock RE. Peptide antibiotics. Lancet 1997; 349: 418-22. (Comment in: Lancet 1997; 349: 1026-7.)
23. Good L, Awasthi SK, Dryselius R, Larsson O, Nielsen PE. Bactericidal antisense effects of peptide-PNA conjugates. Nat Biotechnol 2001; 19: 360-4.
24. Good L, Nielsen PE Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat Biotechnol 1998; 16: 355-8.
25. Kondo N, Kuwahara-Arai K, Kuroda-Murakami H, Tateda-Suzuki E, Hiramatsu K. Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control. Antimicrob Agents Chemother 2001; 45: 815-24.
26. Nekhotiaeva N, Awasthi SK, Nielsen PE, Good L. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Ther 2004; 10: 652-9. (Comment in: Mol Ther 2004; 10: 614-5.)
27. Tan XX, Actor JK, Chen Y. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob Agents Chemother 2005; 49: 3203-7.
28. Kurupati P, Tan KS, Kumarasinghe G, Poh CL. Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneumoniae strain. Antimicrob Agents Chemother 2007; 51: 805-11.
29. Woodford N, Wareham DW. UK Antibacterial Antisense Study Group. Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother 2009; 63: 225-9.
30. Heilmann C, Schweitzer O, Goerke C, Vanittanakom N, Mack D, Götz F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 1996; 20: 1083-91.
31. Goerke C, Kraft A, Süssmuth R, Schweitzer O, Götz F. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem 1998; 273: 18586-93.
32. Cramton SE, Goerke C, Schnell NF, Nichols WW, Götz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999; 67: 5427-33.
33. Arciola CR, Campoccia D, Baldassarri L, Donati ME, Pirini V, Gamberini S, Montanaro L. Detection of biofilm formation in Staphylococcus epidermidis from implant infections. Comparison of a PCR-method that recognizes the presence of ica genes with two classic phenotypic methods. J Biomed Mater Res A 2006; 76: 425-30.
34. Blevins JS, Beenken KE, Elasri MO, Hurlburt BK, Smeltzer MS. Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect Immun 2002; 70: 470-80.
35. Tormo MA, Martí M, Valle J, Manna AC, Cheung AL, Lasa I, Penadés JR. SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development. J Bacteriol 2005; 187: 2348-56.
36. Patti JM, Allen BL, McGavin MJ, Höök M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994; 48: 585-617.
37. Darouiche RO, Landon GC, Patti JM, et al. Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results model-dependent? J Med Microbiol 1997; 46: 75-9.
38. Montanaro L, Arciola CR, Baldassarri L, Borsetti E. Presence and expression of collagen adhesin gene (cna) and slime production in Staphylococcus aureus strains from orthopaedic prosthesis infections. Biomaterials 1999; 20: 1945-9.
39. Tristan A, Ying L, Bes M, Etienne J, Vandenesch F, Lina G. Use of multiplex PCR to identify Staphylococcus aureus adhesins involved in human hematogenous infections. J Clin Microbiol 2003; 41: 4465-7.
40. Vancraeynest D, Hermans K, Haesebrouck F. Genotypic and phenotypic screening of high and low virulence Staphylococcus aureus isolates from rabbits for biofilm formation and MSCRAMMs. Vet Microbiol 2004; 103: 241-7.
41. Arciola CR, Campoccia D, Gamberini S, Baldassarri L, Montanaro L. Prevalence of cna, fnba and fnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol Lett 2005; 246: 81-6.
42. Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, Moghazeh S. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet 1995; 248: 446-58.
43. Balaban N, Goldkorn T, Gov Y, et al. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP). J Biol Chem 2001; 276: 2658-67.
44. Kiran MD, Balaban N. TRAP plays a role in stress response in Staphylococcus aureus. Int J Artif Organs 2009; 32: 592-9.
45. Costerton JW, Montanaro L, Arciola CR. Bacterial communications in implant infections: a target for an intelligence war. Int J Artif Organs 2007; 30: 757-63.
46. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
47. Vadyvaloo V, Otto M. Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medical devices. Int J Artif Organs 2005; 28: 1069-78.
48. Park J, Jagasia R, Kaufmann GF, et al. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem Biol 2007; 14: 1119-27. (Comment in: Chem Biol 2007; 14: 1093-4.)
49. Korem M, Sheoran AS, Gov Y, Tzipori S, Borovok I, Balaban N. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. FEMS Microbiol Lett 2003; 223: 167-75.
50. Balaban N, Goldkorn T, Nhan RT, et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 1998; 280: 438-40. (Comment in: Science 1998; 280: 379; Science 2000; 287: 391).
51. Yang G, Cheng H, Liu C, et al. Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides. Peptides 2003; 24: 1823-8.
52. Kiran MD, Adikesavan NV, Cirioni O, et al. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol 2008; 73: 1578-86.
53. Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Orlando F, Mocchegiani F, Silvestri C, Licci A, Saba V, Scalise G, Balaban N. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis 2006; 193: 180-6.
54. Gov Y, Bitler A, Dell'Acqua G, Torres JV, Balaban N. RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis. Peptides 2001; 22: 1609-20.
55. Balaban N, Collins LV, Cullor JS, et al. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 2000; 21: 1301-11.
56. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 2005; 437: 48-54.
57. Kiran MD, Giacometti A, Cirioni O, Balaban N. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. Int J Artif Organs 2008; 31: 761-70.
58. Balaban N, Cirioni O, Giacometti A, Ghiselli R, Braunstein JB, Silvestri C, Mocchegiani F, Saba V, Scalise G. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 2007; 51: 2226-9.
59. Stender H. PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases. Expert Rev Mol Diagn 2003; 3: 649-55.